JOHNSON & JOHNSON revenue breakdown overview

JOHNSON & JOHNSON revenue for the last year amounted to 391.28 T COP, the most of which — 250.94 T COP — came from its highest performing source at the moment, Innovative Medicine, the year earlier bringing 212.24 T COP. The greatest contribution to the revenue figure was made by United States — last year it brought JOHNSON & JOHNSON 221.59 T COP, and the year before that — 180.02 T COP.